Vendor, Vancouver, CAN
Abcellera Biologics Inc.
UEI D3LSBFZ6MXE3, CAGE L06K8
1 award and $196,000 obligated between February 29, 2024 and February 29, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $196,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30122C14450Definitive Contract, February 29, 2024, Full and Open Competition, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Transgenic Mice for Human Genome AntibodiesNAICS 541714, PSC 8820 | $196,000 |
- Places of performance
- Georgia
- Product and service codes
- 8820 Live Animals, Not Raised for Food
- Transactions
- 1 across 1 awards